SV2004001415A - Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii - Google Patents

Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii

Info

Publication number
SV2004001415A
SV2004001415A SV2002001415A SV2002001415A SV2004001415A SV 2004001415 A SV2004001415 A SV 2004001415A SV 2002001415 A SV2002001415 A SV 2002001415A SV 2002001415 A SV2002001415 A SV 2002001415A SV 2004001415 A SV2004001415 A SV 2004001415A
Authority
SV
El Salvador
Prior art keywords
treatment
pharmaceutical compositions
diabetes
mellitus type
type
Prior art date
Application number
SV2002001415A
Other languages
English (en)
Inventor
Alessandro Tosetti
Mauro Guiducci
Giovanni Viti
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2004001415(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of SV2004001415A publication Critical patent/SV2004001415A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICAS SUMINISTRABLES POR VIA ORAL EN FORMA DE COMPRIMIDOS PARA EL TRATAMIENTO DE LA DIABETES MELLITUS DE TIPO II, QUE COMPRENDEN GLIBENCLAMIDA Y METFORMINA, O SUS SALES FARMACEUTICAMENTE ACEPTABLES, COMO PRINCIPIOS ACTIVOS, MANTENIDOS EN FORMA SEPARADA ENTRE ELLOS EN EL INTERIOR DE LA MISMA COMPOSICION
SV2002001415A 2001-11-29 2002-11-28 Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii SV2004001415A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001FI000230A ITFI20010230A1 (it) 2001-11-29 2001-11-29 Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii

Publications (1)

Publication Number Publication Date
SV2004001415A true SV2004001415A (es) 2004-05-07

Family

ID=11442301

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002001415A SV2004001415A (es) 2001-11-29 2002-11-28 Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii

Country Status (40)

Country Link
US (1) US20050053661A1 (es)
EP (1) EP1458364B1 (es)
JP (1) JP4474162B2 (es)
KR (1) KR20040079898A (es)
CN (1) CN1596103B (es)
AR (1) AR037407A1 (es)
AT (1) ATE387190T1 (es)
AU (1) AU2002358061B2 (es)
BR (1) BR0214403A (es)
CA (1) CA2466677A1 (es)
CO (1) CO5590906A2 (es)
CY (1) CY1107966T1 (es)
DE (1) DE60225331T2 (es)
DK (1) DK1458364T3 (es)
EA (1) EA006766B1 (es)
EG (1) EG24124A (es)
ES (1) ES2302862T3 (es)
HK (1) HK1069974A1 (es)
HN (1) HN2002000341A (es)
HR (1) HRP20040501A2 (es)
HU (1) HUP0402154A3 (es)
IL (1) IL162143A0 (es)
IT (1) ITFI20010230A1 (es)
MA (1) MA27087A1 (es)
MX (1) MXPA04004974A (es)
MY (1) MY141243A (es)
NO (1) NO20042713L (es)
NZ (1) NZ533779A (es)
PA (1) PA8559801A1 (es)
PE (1) PE20030580A1 (es)
PL (1) PL206016B1 (es)
PT (1) PT1458364E (es)
RS (1) RS50937B (es)
SI (1) SI1458364T1 (es)
SV (1) SV2004001415A (es)
TN (1) TNSN04095A1 (es)
UA (1) UA81615C2 (es)
UY (1) UY27549A1 (es)
WO (1) WO2003045355A1 (es)
ZA (1) ZA200404880B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4633329B2 (ja) * 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
ATE388698T1 (de) 2003-04-29 2008-03-15 Orexigen Therapeutics Inc Zusammensetzungen zur beeinflussung des gewichtsverlusts
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
JP2010509367A (ja) * 2006-11-09 2010-03-25 オレキシジェン・セラピューティクス・インコーポレーテッド 積層製剤
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
JP2011521973A (ja) 2008-05-30 2011-07-28 オレキシジェン・セラピューティクス・インコーポレーテッド 内臓脂肪の状態を処置するための方法
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
KR20120124423A (ko) 2010-01-11 2012-11-13 오렉시젠 세러퓨틱스 인크. 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
RU2483717C2 (ru) * 2010-11-22 2013-06-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения диабета (варианты)
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
EP3763419A1 (en) 2011-01-07 2021-01-13 Anji Pharma (US) LLC Chemosensory receptor ligand-based therapies
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
NZ626578A (en) 2012-01-06 2016-11-25 Elcelyx Therapeutics Inc Compositions and methods for treating metabolic disorders
JP2015503582A (ja) 2012-01-06 2015-02-02 エルセリクス セラピューティクス インコーポレイテッド ビグアナイド組成物および代謝障害を治療する方法
PT3730132T (pt) 2012-06-06 2022-08-16 Nalpropion Pharmaceuticals Llc Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular
CN107072997A (zh) 2014-11-11 2017-08-18 盐野义制药株式会社 含有对光不稳定的药物的多层片剂
KR101750690B1 (ko) * 2015-10-28 2017-06-27 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) * 2015-12-23 2016-05-25 青岛海之源智能技术有限公司 一种二甲双胍阿昔莫司复方组合物及制备方法
CN110128305A (zh) * 2019-05-10 2019-08-16 天津大学 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
AP1224A (en) * 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
PT974356E (pt) * 1998-07-15 2004-02-27 Merck Sante Sas Comprimidos compreendendo uma combinacao de metformina e de glibenclamida
US6780432B1 (en) * 2000-05-01 2004-08-24 Aeropharm Technology, Inc. Core formulation
JP4633329B2 (ja) * 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム

Also Published As

Publication number Publication date
ITFI20010230A1 (it) 2003-05-29
SI1458364T1 (sl) 2008-08-31
EP1458364B1 (en) 2008-02-27
HN2002000341A (es) 2009-12-07
HUP0402154A3 (en) 2008-04-28
IL162143A0 (en) 2005-11-20
PE20030580A1 (es) 2003-09-05
PT1458364E (pt) 2008-05-26
MY141243A (en) 2010-03-31
PL369851A1 (en) 2005-05-02
US20050053661A1 (en) 2005-03-10
JP2005518360A (ja) 2005-06-23
HUP0402154A2 (hu) 2005-02-28
RS47304A (en) 2006-10-27
MXPA04004974A (es) 2004-08-11
ZA200404880B (en) 2005-07-29
AU2002358061A1 (en) 2003-06-10
AR037407A1 (es) 2004-11-10
EA200400664A1 (ru) 2004-10-28
WO2003045355A1 (en) 2003-06-05
UA81615C2 (ru) 2008-01-25
JP4474162B2 (ja) 2010-06-02
CN1596103B (zh) 2010-06-16
HK1069974A1 (en) 2005-06-10
AU2002358061B2 (en) 2007-01-11
EG24124A (en) 2008-07-07
TNSN04095A1 (en) 2006-06-01
NO20042713L (no) 2004-07-16
HRP20040501A2 (en) 2004-12-31
CO5590906A2 (es) 2005-12-30
PA8559801A1 (es) 2003-06-30
PL206016B1 (pl) 2010-06-30
DE60225331T2 (de) 2009-02-26
BR0214403A (pt) 2004-10-19
EP1458364A1 (en) 2004-09-22
CY1107966T1 (el) 2013-09-04
CN1596103A (zh) 2005-03-16
DE60225331D1 (de) 2008-04-10
MA27087A1 (fr) 2004-12-20
ES2302862T3 (es) 2008-08-01
DK1458364T3 (da) 2008-06-23
ATE387190T1 (de) 2008-03-15
KR20040079898A (ko) 2004-09-16
EA006766B1 (ru) 2006-04-28
CA2466677A1 (en) 2003-06-05
NZ533779A (en) 2007-02-23
UY27549A1 (es) 2003-06-30
RS50937B (sr) 2010-08-31

Similar Documents

Publication Publication Date Title
SV2004001415A (es) Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
ECSP055853A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
CL2009001059A1 (es) Compuestos derivados de 1,3-oxazin-2-ona-3,6 sustituidos, inhibidores de la actividad de la 11-beta-hidroxiesteroide deshidrogenasa i; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades tales como diabetes mellitus, entre otras.
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
PA8577101A1 (es) Nuevos derivados de glicosido de tiofeno, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos
UY28510A1 (es) Compuestos quimicos
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
UY29633A1 (es) Derivados de oxindol
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
CL2008003096A1 (es) Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras.
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
PA8580301A1 (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
UY28348A1 (es) Compuestos novedosos
PA8669801A1 (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
GT200000199A (es) Cristal de 4-carboxamino-1,2,3,4-tetrahidroquinolina-2-sustituida.
HN2003000379A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
ECSP088250A (es) Derivados de pirazol como agentes terapéuticos
CL2007003223A1 (es) Compuestos derivados de piperidinil 4-arilsulfonamidas n-sustituidas, que actuan como moduladores de la proteina sfrp-1; proceso para preparar los compuestos; co mposicion farmaceutica que comprende a dichos copmpuestos y uso de los compuestos para preparar medicamentos para el tratamiento de enfermedades.
GT200600130A (es) Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia
CR10255A (es) "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos"
ECSP088219A (es) Nueva sal i

Legal Events

Date Code Title Description
FD Lapse